A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2011
11/30/2011	CN101766799B 参附蜈蚣保健酒 Shenfu centipede health wine
11/30/2011	CN101757106B 一种用于清热解毒的注射液及其制备方法 Injection and its preparation method for detoxification
11/30/2011	CN101757009B 三七皂苷Rgl在制备治疗肺间质纤维化药物中的应用 Notoginsenoside Rgl use in the treatment of pulmonary fibrosis between the preparation of a medicament
11/30/2011	CN101716141B 一种氟罗沙星注射液及其制备方法 An injection Fleroxacin fluoride and its preparation method
11/30/2011	CN101703601B 预防和治疗鸡败血支原体病的中药组合物及其制备方法 Prevention and treatment of disease Mycoplasma gallisepticum Chinese medicine composition and its preparation method
11/30/2011	CN101623469B 一种古威活络酊的检测方法 An ancient method of detecting active Viagra tincture
11/30/2011	CN101575365B 一种抗病毒蛋白及其制备方法和应用 An anti-viral protein and its preparation method and application
11/30/2011	CN101549021B 杠板归药材的检测方法 Perfoliatum detection herbs
11/30/2011	CN101537033B 一种防治支气管哮喘的中药制剂及其制备方法 A bronchial asthma prevention medicine and its preparation method
11/30/2011	CN101516893B 5,7-二取代的[1,3]噻唑并[4,5-d]嘧啶-2(3h)-酮衍生物和它们在治疗中的用途 5,7-disubstituted [1,3] thiazolo [4,5-d] pyrimidin -2 (3h) - one derivatives and their use in therapy
11/30/2011	CN101474282B 一种治疗支气管哮喘的中药化合物及其制备方法 Chinese medicinal compounds and methods of treatment of bronchial asthma
11/30/2011	CN101474270B 一种克咳片 One kind grams cough tablets
11/30/2011	CN101474256B 一种苍耳子鼻炎软胶囊制剂及其制备方法 One kind of Xanthium rhinitis soft capsule and its preparation method
11/30/2011	CN101474255B 苍耳子鼻炎胶囊的检测方法 Detection Xanthium rhinitis capsule
11/30/2011	CN101194906B 一种用于治疗过敏性疾病的滴丸及其制备方法 Dropping Pills and its preparation method for the treatment of allergic diseases
11/30/2011	CN101104050B 一种治疗肝火犯肺型咽炎的汤剂药物及制备方法 A treatment for pharyngitis decoction anger Fanfei type drugs and preparation methods
11/29/2011	US8067674 Desaturase genes, enzymes encoded thereby, and uses thereof
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067564 Methods of obtaining a specific binding member that binds eotaxin
11/29/2011	US8067437 Beta-2-adrenoreceptor agonists
11/29/2011	US8067426 6-amino-purin-8-one compounds
11/29/2011	US8067413 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
11/29/2011	US8067411 Compounds
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067388 Decoy-containing pharmaceutical compositions and method of using the same
11/29/2011	US8067016 Fusion proteins of Mycobacterium tuberculosis
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2658359C Heterocyclic compounds and methods of use
11/29/2011	CA2507502C Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists
11/29/2011	CA2494302C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
11/29/2011	CA2486910C Ophthalmological use of roflumilast for the treatment of diseases of the eye
11/29/2011	CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011	CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/29/2011	CA2401241C 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
11/24/2011	WO2011146471A1 Treatment for altitudinal hypoxia
11/24/2011	WO2011146031A1 Pharmaceutical composition comprising n- acetylcysteine and a xanthine
11/24/2011	WO2011145642A1 Pharmaceutical composition containing solifenacin
11/24/2011	WO2011144584A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
11/24/2011	WO2011144501A1 Ccr2 antagonists and uses thereof
11/24/2011	WO2011143844A1 Traditional chinese medicine composition for treating infection of influenza a virus subtype and preparation method thereof
11/24/2011	WO2011143843A1 Atomizing formulation comprising plant extract and its preparation method
11/24/2011	WO2011110861A3 Therapy for influenza like illness
11/24/2011	WO2011109833A3 Induced dendritic cell compositions and uses thereof
11/24/2011	WO2011084513A3 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
11/24/2011	WO2011038097A3 Indolizine inhibitors of 5-lipoxygenase
11/24/2011	WO2010134047A3 Liquid dosage forms of isotretinoin
11/24/2011	US20110289608 Antisense modulation of interleukins 17 and 23 signaling
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288161 Methods for treatment of thiol-containing compound deficient conditions
11/24/2011	US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288155 Sirna compounds and methods of use thereof
11/24/2011	US20110288154 RNA Interference Mediated Inhibition of Epithelial Sodium Channel (ENaC) Gene Expression Using Short Interfering Nucleic Acid (siNA)
11/24/2011	US20110288134 Composition and method for treating fibrosis
11/24/2011	US20110288129 Amide derivatives as trpv1 antagonists
11/24/2011	US20110288122 Pharmaceutical Compositions and Administrations Thereof
11/24/2011	US20110288121 Processes for Producing Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
11/24/2011	US20110288120 Isoquinolinone derivatives as nk3 antagonists
11/24/2011	US20110288118 Pharmaceutical composition comprising solifenacin
11/24/2011	US20110288115 Treatment of vagally-mediated spectrum disorders
11/24/2011	US20110288103 Compounds, compositions, and methods comprising 1,3,4-oxadiazole derivatives
11/24/2011	US20110288098 Novel compounds
11/24/2011	US20110288097 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288093 Compounds, Compositions, and Methods Comprising Pyridazine Sulfonamide Derivatives
11/24/2011	US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
11/24/2011	US20110288073 Alpha-Aminocyclolactam Ligands for G-protein Coupled Receptors, and Methods of Using Same
11/24/2011	US20110288067 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288066 Phenoxy acetic acid derivatives
11/24/2011	US20110288060 apparatus and process for producing crystals
11/24/2011	US20110288011 Peptide therapeutic conjugates and uses thereof
11/24/2011	US20110288005 Alpha 1-antitrypsin compositions and methods of making and using same
11/24/2011	US20110288004 Viral Sequences and Uses Thereof
11/24/2011	US20110287103 Sustained-release formulations of topiramate
11/24/2011	US20110287071 Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs
11/24/2011	US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/24/2011	US20110287040 Materials and methods for treatment of inflammation
11/24/2011	US20110287031 Covalently reactive transition state analogs and methods of use thereof
11/24/2011	US20110287017 Anti-p-selectin antibodies and methods of their use and identification
11/24/2011	US20110287007 Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6
11/24/2011	US20110286986 Lactoferrin and angiogenin compositions and uses thereof
11/24/2011	US20110286972 Virus growing in hypoxic cell or virus vector expressing gene therein
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	CA2799942A1 Pharmaceutical composition containing solifenacin
11/24/2011	CA2798970A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
11/24/2011	CA2790170A1 Treatment for altitudinal hypoxia
11/23/2011	EP2388277A2 Human anti-B7RP1 neutralizing antibodies
11/23/2011	EP2388276A2 Human anti-B7RP1 neutralizing antibodies
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2388010A1 Use of non-digestible saccharides for giving an infant the best start after birth
11/23/2011	EP2387440A2 Quinazolinone derivatives useful as vanilloid antagonists
11/23/2011	EP2387329A1 Honey product having a low water content
11/23/2011	EP2021797B1 Compositions of n-ý2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl¨-1,4-dihydro-4-oxoquinoline-3-carboxamide
11/23/2011	EP2004576B1 New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use
11/23/2011	EP1864659B1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
11/23/2011	EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011	EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	EP1137439B2 Stabilization of rapamycins or derivatives of rapamycins
11/23/2011	CN1973884B Bobei throat-fitting buccal tablet
11/23/2011	CN102256995A Cyclic depsipeptide compound and use thereof

1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 878